Development and Validation of a Nomogram Integrating Body Composition and Inflammatory Markers to Predict Concurrent Chemoradiotherapy Response in Locally Advanced Cervical Cancer
Lina Liu, Qianqian Zhang, Lele Liu, Zhenzhen Wu, Xingxia Zhang, Jianli Qiao, Mali Chen · 2026
Read Development and Validation of a Nomogram Integrating Body Composition and Inflammatory Markers to Predict Concurrent Chemoradiotherapy Response in Locally Advanced Cervical Cancer by Lina Liu, Qianqian Zhang, Lele Liu, Zhenzhen Wu, Xingxia Zhang, Jianli Qiao, Mali Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13267815.txt.
Description
Lina Liu and colleagues wrote a 2026 study building a prediction chart for cervical cancer treatment response. Locally advanced cervical cancer is treated with chemotherapy and radiation given together. Response varies, and a tool to foresee it could shape care. The team studied 215 patients treated at one center between 2020 and 2024.
Five factors independently predicted a good response: tumor size, an inflammation ratio from blood counts, a nutrition index, muscle amount, and belly fat amount from scans. The team combined them into a nomogram, a chart that turns measures into a personal chance score. The chart sorted responders from non-responders fairly well in both its building group and a held-back test group. It beat simpler models using only one factor family. Wider testing is still needed.
Catalog record
| CREATOR | Lina Liu, Qianqian Zhang, Lele Liu, Zhenzhen Wu, Xingxia Zhang, Jianli Qiao, Mali Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38753 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |